Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease

Journal of Neuroimmunology

Volumn 75, Issue 1-2, 1997, Pages 59-68

  Svenningsson, Anders ^a,d   Dotevall, Leif ^b   Stemme, Sten ^c   Andersen, Oluf ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

B7; cerebrospinal fluid; costimulatory molecules; flow cytometry; multiple sclerosis

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS; ANTIGENS, CD80; B-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROSPINAL FLUID; ENCEPHALITIS; FLOW CYTOMETRY; HUMANS; INFECTION; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS;

EID: 0030996263     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00234-2     Document Type: Article

References (56)

1. Allison, J.P. (1994) CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol. 6, 414-419.
2. Alvord, Jr, E.C., Jahnke, U., Fischer, E.H. et al. (1987) The multiple causes of multiple sclerosis: The importance of age of infections in childhood. J. Child Neurol. 2, 313-321.
3. Andersen, O., Lygner, P.-E., Bergström, T. et al. (1993) Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study. J. Neurol. 240, 417-422.
4. Azuma, M., Ito, D., Yagita, H. et al. (1993a) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76-79.
5. - T lymphocytes. Antigenic and functional properties. J. Immunol. 150, 1147-1159.
6. Azuma, M., Yssel, H., Phillips, J.H. et al. (1993e) Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177, 845-850.
7. Boussiotis, V.A., Freeman, G.J., Gray, G. et al. (1993) B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J. Exp. Med. 178, 1753-1763.
8. Brodsky, F.M. and Guagliardi, L.E. (1991) The cell biology of antigen processing and presentation. Annu. Rev. Immunol. 9, 707-744.
9. Burkly, L.C., Lo, D. and Flavell, R.A. (1990) Tolerance in transgenic mice expressing major histocompatibility molecules extrathymically on pancreatic cells. Science 248, 1364-1368.
10. Compston, D.A.S., Vakarelis, B.N., McDonald, P.W.I. et al. (1986) Viral infections in patients with multiple sclerosis and HLA-DR matched controls. Brain 109, 325-344.
11. Cross, A.H., Girard, T.J., Giacoletto, K.S. et al. (1995) Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J. Clin. Invest. 95, 2783-2789.
12. Damle, N.K. and Engleman, E.G. (1989) Antigen-specific suppressor T lymphocytes in man. Clin. Immunol. Immunopathol. 53(Suppl), S17-S24.
13. Damle, N.K., Mohagheghpour, N., Hansen, J.A. and Engleman, E.G. (1983) Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. J. Immunol. 131, 2296-2300.
14. de Simone, R., Giampaolo, A., Giometto, B. et al. (1995) The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol. 54, 175-187.
15. Freedman, A.S., Freeman, G.J., Rhynhart, K. and Nadler, L.M. (1991) Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol. 137, 429-437.
16. Freeman, G.J., Freedman, A.S., Segil, J.M. et al. (1989) B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143, 2714-2722.
17. Freeman, G.J., Gribben, J.G., Boussiotis, V.A. et al. (1993) Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262, 909-911.
18. Gimmi, C.D., Freeman, G.J., Gribben, J.G. et al. (1993) Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA 90, 6586-6590.
19. Gimmi, C.D., Freeman, G.J., Gribben, J.G. et al. (1991) B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88, 6575-6579.
20. Guerder, S., Picarella, D.E., Linsley, P.S. and Flavell, R.A. (1994) Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor a leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91, 5138-5142.
21. Hafler, D.A., Benjamin, D.S., Burks, J. and Weiner, H.L. (1987) Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis. J. Immunol. 139, 68-72.
22. Harding, F.A., McArthur, J.G., Gross, J.A. et al. (1992) CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607-609.
23. Heath, W.R., Allison, J., Hoffmann, M.W. et al. (1992) Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 359, 547-549.
24. June, C.H., Ledbetter, J.A., Linsley, P.S. and Thompson, C.B. (1990) Role of the CD28 receptor in T-cell activation. Immunol. Today 11, 211-216.
25. Khoury, S.J., Akalin, E., Chandraker, A. et al. (1995) CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 155, 4521-4524.
26. Krummel, M.F. and Allison, J.P. (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-465.
27. Kuchroo, V.K., Prabhu Das, M., Brown, J.A. et al. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80, 707-718.
28. Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33, 1444-1452.
29. Lanzavecchia, A. (1993) Identifying strategies for immune intervention. Science 260, 937-944.
30. Lassmann, H. and Wisniewsky, H.M. (1979) Chronic relapsing experimental allergic encephalomyelitis. Clinicopathological comparison with multiple sclerosis. Arch. Neurol. 36, 490-497.
31. Leibowitz, U., Kahana, E., Israel, J. and Alter, M. (1973) The changing frequency of multiple sclerosis in Israel. Arch. Neurol. 29, 107-110.
32. Lenschow, D.J. and Bluestone, J.A. (1993) T cell co-stimulation and in vivo tolerance. Curr. Opin. Immunol. 5, 747-752.
33. Lindsten, T., June, C.H., Ledbetter, J.A. et al. (1989) Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244, 339-343.
34. Lindsten, T., Lee, K.P., Harris, E.S. et al. (1993) Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 151, 3489-3499.
35. Linsley, P.S., Brady, W., Grosmaire, L. et al. (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173, 721-730.
36. Linsley, P.S., Greene, J.L., Brady, W. et al. (1994) Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but different kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793-801.
37. Linsley, P.S. and Ledbetter, J.A. (1993) The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191-212.
38. Lum, L.G., Orcutt, T.N., Seigneuret, M.C. and Hansen, J.A. (1982) In vitro regulation of immunoglobulin synthesis by T-cell subpopulations defined by a new human T-cell antigen (9.3). Cell Immunol. 72, 122-129.
39. Miller, J.F.A.P., Morahan, G. and Allison, J. (1989) Extrathymic acquisition of tolerance by T lymphocytes. Cold Spring Harbor Symp. Quant. Biol. 54, 807-813.
40. Morahan, G., Allison, J. and Miller, J.F.A.P. (1989) Tolerance of class I histocompatibility antigens expressed extrathymically. Nature 339, 622-624.
41. Mueller, D.L., Jenkins, M.K. and Schwartz, R.H. (1989) An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness. J. Immunol. 142, 2617-2628.
42. Poser, C.M., Paty, D.W., Scheinberg, L. et al. (1983) New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann. Neurol. 13, 227-231.
43. Racke, M.K., Scott, D.E., Quigley, L. et al. (1995) Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96, 2195-2203.
44. Sinha, A.A., Lopez, M.T. and McDevitt, H.O. (1990) Autoimmune diseases: The failure of self tolerance. Science 248, 1380-1388.
45. Spruyt, L.L., Glennie, M.J., Beyers, A.D. and Williams, A.F. (1991) Signal transduction by the CD2 antigen in T cells and natural killer cells: Requirement for expression of a functional T cell receptor or binding of antibody Fc to the Fc receptors, FcγRIIIA (CD16). J. Exp. Med. 174, 1407-1415.
46. Svenningsson, A., Andersen, O., Edsbagge, M. and Stemme, S. (1995) Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J. Neuroimmunol. 63, 39-46.
47. Svenningsson, A., Hansson, G.K., Andersen, O. et al. (1993) Adhesion molecule expression on cerebrospinal fluid T lymphocytes. Evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann. Neurol. 34, 155-161.
48. Trinchieri, G. (1989) Biology of natural killer cells. Adv. Immunol. 47, 187-376.
49. + naive T cells can be efficiently activated by remote co-stimulation with B7. Int. Immunol. 5, 1483-1487.
50. van Seventer, G.A., Shimizu, Y., Morgan, K.J. and Shaw, S. (1990) The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144, 4579-4586.
51. Vandenberghe, P., Delabie, J., de, B.M. et al. (1993) In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: An immunohistochemical study. Int. Immunol. 5, 317-321.
52. von Boehmer, H. (1993) The developmental biology of T lymphocytes. Annu. Rev. Immunol. 6, 309-326.
53. Waterhouse, P., Penninger, J.M., Timms, E. et al. (1995) Lymphoproliferative disorder with early lethality in mice deficient in Ctla-4. Science 270, 985-987.
54. Weinshenker, B.G. and Sibley, W.A. (1992) Natural history and treatment of multiple sclerosis. Curr. Opin. Neurol. Neurosurg. 5, 203-211.
55. Williams, K., Ulvestad, E. and Antel, J.P. (1994) B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24, 3031-3037.
56. Windhagen, A., Newcombe, J., Dangond, F. et al. (1995) Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182, 1985-1996.